M3, Inc.
General ticker "MTHRF" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $8.8B (TTM average)
M3, Inc. does not follow the US Stock Market performance with the rate: -32.3%.
Estimated limits based on current volatility of 0.0%: low 8.55$, high 8.55$
Factors to consider:
- Earnings expected soon, date: nan
- Company pays dividends (annually): last record date 2026-03-31, amount 0.14$ (Y1.64%)
- Earnings for 12 months up through Q4 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-03-31 to 2027-03-31
- 2025-03-31 to 2026-03-31 estimated range: [7.19$, 13.79$]
- 2026-03-31 to 2027-03-31 estimated range: [7.06$, 13.62$]
Financial Metrics affecting the MTHRF estimates:
- Positive: with PPE of 24.7 at the end of fiscal year the price was low
- Positive: Operating profit margin, % of 22.10 > 18.65
- Negative: Operating cash flow per share per price, % of 5.38 <= 6.73
- Negative: Shareholder equity ratio, % of 65.05 > 63.79
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.51 > 6.08
- Negative: negative Industry operating income (median)
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
- Negative: Investing cash flow per share per price, % of -4.07 <= -0.65
Short-term MTHRF quotes
Long-term MTHRF plot with estimates
Financial data
| YTD | 2023-03-31 | 2024-03-31 | 2025-03-31 |
|---|---|---|---|
| Operating Revenue | ¥230,818.00MM | ¥238,883.00MM | ¥284,900.00MM |
| Operating Expenses | ¥158,835.00MM | ¥174,502.00MM | ¥221,929.00MM |
| Operating Income | ¥71,983.00MM | ¥64,381.00MM | ¥62,971.00MM |
| Non-Operating Income | ¥2,335.00MM | ¥4,459.00MM | ¥1,814.00MM |
| Interest Expense | ¥69.00MM | ¥391.00MM | ¥717.00MM |
| Income(Loss) | ¥74,318.00MM | ¥68,840.00MM | ¥64,785.00MM |
| Taxes | ¥22,336.00MM | ¥20,291.00MM | ¥20,444.00MM |
| Net Income(Loss)* | ¥49,028.00MM | ¥45,271.00MM | ¥40,484.00MM |
| Stockholders Equity | ¥302,630.00MM | ¥351,915.00MM | ¥378,436.00MM |
| Inventory | ¥1,975.00MM | ¥0.00MM | ¥0.00MM |
| Assets | ¥400,645.00MM | ¥490,780.00MM | ¥581,741.00MM |
| Operating Cash Flow | ¥57,113.00MM | ¥58,310.00MM | ¥51,743.00MM |
| Capital expenditure | ¥7,577.00MM | ¥7,581.00MM | ¥8,991.00MM |
| Investing Cash Flow | ¥-21,933.00MM | ¥-39,456.00MM | ¥-39,149.00MM |
| Financing Cash Flow | ¥-22,837.00MM | ¥9,432.00MM | ¥-27,165.00MM |
| Earnings Per Share** | ¥72.22 | ¥66.68 | ¥59.62 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.